HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.

AbstractOBJECTIVE:
Tumor necrosis factor-beta (TNF-β), as an inflammatory mediator that has been shown to promote tumorigenesis, induces NF-κB. Natural multi-targeted agent resveratrol in turn shows anti-inflammatory and anti-cancer properties. Epithelial-to-mesenchymal transition (EMT) allows cancer cells to turn into a motile state with invasive capacities and is associated with metastasis and development of cancer stem cells (CSC). However, TNF-β-induced EMT and the anti-invasion mechanism of resveratrol on CRC are not yet completely understood.
METHODS:
We investigated the underlying molecular mechanisms of resveratrol on TNF-β/TNF-βR-induced EMT and migration of CRC cells (HCT116, RKO, SW480) in monolayer or 3D alginate cultures.
RESULTS:
TNF-β, similar to TNF-α, induced significant cell proliferation, morphological change, from an epithelial to a spindle-like mesenchymal shape with the formation of filopodia and lamellipodia associated with the expression of EMT parameters (elevated vimentin and slug, reduced E-cadherin), increased migration/invasion, and formation of CSC in all CRC cells. Interestingly, these effects were dramatically decreased in the presence of resveratrol or anti-TNF-βR with TNF-β co-treatment, inducing biochemical changes to the mesenchymal-epithelial transition (MET), with a planar cell surface and suppressed formation of CSC cells. This was associated with a significant increase in apoptosis. Furthermore, we found that resveratrol suppressed TNF-β-induced NF-κB and NF-κB-regulated gene biomarkers associated with growth, proliferation, and invasion. Finally, TNF-βR interacts directly with focal adhesion kinase (FAK) and NF-κB.
CONCLUSION:
These results suggest that resveratrol down-regulates TNF-β/TNF-βR-induced EMT, at least in part via specific suppression of NF-κΒ and FAK in CRC cells.
AuthorsConstanze Buhrmann, Mina Yazdi, Bastian Popper, Ajaikumar B Kunnumakkara, Bharat B Aggarwal, Mehdi Shakibaei
JournalNutrients (Nutrients) Vol. 11 Issue 3 (Mar 26 2019) ISSN: 2072-6643 [Electronic] Switzerland
PMID30917533 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Lymphotoxin-alpha
  • NF-kappa B
  • Receptors, Tumor Necrosis Factor
  • Focal Adhesion Kinase 1
  • PTK2 protein, human
  • Resveratrol
Topics
  • Biomarkers, Tumor
  • Cell Line, Tumor
  • Cell Membrane
  • Cell Movement (drug effects)
  • Cell Survival (drug effects)
  • Colorectal Neoplasms (metabolism)
  • Down-Regulation
  • Epithelial-Mesenchymal Transition (drug effects, physiology)
  • Focal Adhesion Kinase 1 (metabolism)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Lymphotoxin-alpha (pharmacology)
  • NF-kappa B
  • Receptors, Tumor Necrosis Factor
  • Resveratrol (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: